zoledronic acid has been researched along with Sarcoma 180 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, D; Deng, Y; Hu, H; Qiao, M; Zang, X; Zhang, X; Zhao, X | 1 |
1 other study(ies) available for zoledronic acid and Sarcoma 180
Article | Year |
---|---|
Targeted Delivery of Zoledronate to Tumor-Associated Macrophages for Cancer Immunotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Hydrogen-Ion Concentration; Immunotherapy; Inhibitory Concentration 50; Injections, Intraventricular; Lipids; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nanoparticles; Neovascularization, Pathologic; RAW 264.7 Cells; Sarcoma 180; Tissue Distribution; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays; Zoledronic Acid | 2019 |